We are live on
!
Find out more
PSC
Prentiss Smith & Co Portfolio holdings
AUM
$182M
Turnover
8.7%
1-Year Est. Return
26.44%
This Fund
S&P 500
This Quarter
Est. Return
+7.4%
1 Year Est. Return
+26.44%
3 Year Est. Return
+63.89%
5 Year Est. Return
+57.29%
10 Year Est. Return
+270.92%
AUM
$173M
AUM Growth
-$17.9M
(-9.3%)
Cap. Flow
-$30.2M
Cap. Flow
% of AUM
-17.43%
Top 10 Holdings %
Top 10 Hldgs %
55.08%
Holding
288
New
38
Increased
28
Reduced
38
Closed
40
Avg Time Held
2.2
years
Top 10 Avg Time Held
1.9
years
Top 20 Avg Time Held
1.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$4.21M |
| 2 |
CERN
Cerner Corp
CERN
|
+$1.19M |
| 3 |
UMPQ
Umpqua Holdings Corp
UMPQ
|
+$656K |
| 4 |
Danaher
DHR
|
+$524K |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$443K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$8.2M |
| 2 |
United Parcel Service
UPS
|
+$6.58M |
| 3 |
F5
FFIV
|
+$6.21M |
| 4 |
First Solar
FSLR
|
+$3.71M |
| 5 |
ORBK
Orbotech Ltd
ORBK
|
+$2.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.47% |
| 2 | Technology | 20.82% |
| 3 | Communication Services | 13.22% |
| 4 | Financials | 11.36% |
| 5 | Industrials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
WGL
151
DELISTED
Wgl Holdings
WGL
| $26K | 0.02% |
310
| – | – |
2013 Q2
17 quarters
|
|
152
Eversource Energy
ES
$25.2B
| $25K | 0.01% |
413
| – | – |
2013 Q2
17 quarters
|
|
153
Invesco Senior Loan ETF
BKLN
$6.27B
| $23K | 0.01% |
1,000
| – | – |
2017 Q1
2 quarters
|
|
154
abrdn Healthcare Opportunities Fund
THQ
$743M
| $23K | 0.01% |
+1,250
| New | +$22.9K |
2017 Q3
0 quarters
|
|
155
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
$494M
| $22K | 0.01% |
1,125
| – | – |
2014 Q4
11 quarters
|
|
156
Vanguard Real Estate ETF
VNQ
$36.8B
| $22K | 0.01% |
268
| – | – |
2017 Q2
1 quarter
|
|
157
Weyerhaeuser
WY
$14.1B
| $22K | 0.01% |
648
| – | – |
2017 Q2
1 quarter
|
|
158
IDEX
IEX
$17.4B
| $21K | 0.01% |
170
| – | – |
2013 Q2
17 quarters
|
|
159
iShares Core S&P 500 ETF
IVV
$880B
| $21K | 0.01% |
+85
| New | +$21.1K |
2017 Q3
0 quarters
|
|
160
CSX Corp
CSX
$90.2B
| $20K | 0.01% |
1,089
| – | – |
2015 Q4
7 quarters
|
|
161
iShares US Real Estate ETF
IYR
$4.18B
| $20K | 0.01% |
+250
| New | +$20.1K |
2017 Q3
0 quarters
|
|
162
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
$1.36B
| $20K | 0.01% |
1,500
| – | – |
2015 Q2
9 quarters
|
|
163
SolarEdge
SEDG
$1.93B
| $20K | 0.01% |
700
| – | – |
2017 Q2
1 quarter
|
|
|
FMI
164
DELISTED
Foundation Medicine, Inc.
FMI
| $20K | 0.01% |
500
| – | – |
2017 Q2
1 quarter
|
|
|
MULE
165
DELISTED
MuleSoft, Inc.
MULE
| $20K | 0.01% |
1,000
| – | – |
2017 Q2
1 quarter
|
|
166
Vanguard Intermediate-Term Bond ETF
BIV
$28.4B
| $19K | 0.01% |
229
| – | – |
2016 Q4
3 quarters
|
|
167
WisdomTree Emerging Markets Local Debt Fund
ELD
$138M
| $19K | 0.01% |
502
| – | – |
2014 Q1
14 quarters
|
|
168
SLB Ltd
SLB
$73.5B
| $18K | 0.01% |
251
| – | – |
2013 Q2
17 quarters
|
|
169
Teva Pharmaceutical Industries Limited
TEVA
$48.4B
| $18K | 0.01% |
1,000
| – | – |
2016 Q4
3 quarters
|
|
170
Toyota
TM
$229B
| $18K | 0.01% |
150
| – | – |
2014 Q4
11 quarters
|
|
171
Eaton Vance Tax-Managed Diversified Equity Income Fund
ETY
$2.2B
| $17K | 0.01% |
1,500
| – | – |
2015 Q2
9 quarters
|
|
172
General Mills
GIS
$17.7B
| $17K | 0.01% |
334
| – | – |
2016 Q4
3 quarters
|
|
173
Hubbell
HUBB
$24.4B
| $17K | 0.01% |
150
| – | – |
2017 Q2
1 quarter
|
|
174
iShares Core S&P Mid-Cap ETF
IJH
$121B
| $17K | 0.01% |
+470
| New | +$16.4K |
2017 Q3
0 quarters
|
|
175
Invesco Floating Rate Municipal Income ETF
PVI
$33.7M
| $17K | 0.01% |
666
| – | – |
2016 Q4
3 quarters
|
|
Similar funds
LAM
MPW
FNBOH
CAM
PW
DRC
MW
EWA
Prentiss Smith & Co's Q3 2017 Portfolio in Review
As of Q3 2017, Prentiss Smith & Co held 288 positions worth $173M, down 9.3% from $191M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Prentiss Smith & Co withdrew a net $30.2M in Q3 2017, closing 40 positions and reducing 38 holdings. Its most notable exit was F5, an estimated $6.21M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 26% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Prentiss Smith & Co opened a new position in Regeneron Pharmaceuticals worth $416K.
- Prentiss Smith & Co's largest Q3 2017 buy was Regeneron Pharmaceuticals: 931 shares worth $416K.
- Prentiss Smith & Co added most to Oracle in Q3 2017, an estimated $4.21M increase.
- Prentiss Smith & Co's biggest Q3 2017 reduction was Verizon, cutting an estimated $8.2M.
- Prentiss Smith & Co fully exited F5 in Q3 2017, selling an estimated $6.21M.
- Prentiss Smith & Co's ten largest holdings make up 55% of its $173M portfolio in Q3 2017.
- Prentiss Smith & Co opened 38 new positions and closed 40 in Q3 2017.
- Prentiss Smith & Co's portfolio value fell 9.3% quarter-over-quarter to $173M.
Based on Prentiss Smith & Co's 13F filing for Q3 2017, filed 23 Oct 2017.